RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. VitriVax

VitriVax

VitriVax develops thermostable, single-dose vaccine formulations, starting with a single-dose Lyme disease vaccine.

Latest funding

$87M Series B+ ·

Led by F-Prime Capital · Source: thepharmaletter.com

Total raised: $104.25M across 2 sourced rounds

All 3 rounds ↓
Website: vitrivaxbio.com.
LinkedIn: vitrivax.
Category: Health and bio.
Stage: Series B+.
Total raised: $104.25M in 2 sourced rounds.
Last round: Nov 19, 2026 · 3 days ago.
Headcount: 51–100 employees.
On Recent Funding since: Nov 20, 2026.

Signals

Website registeredSep 16, 2018 (8 years old)
TIMELINE · MONEY RAISED

VitriVax | 1964 days on the record

Raised $104M in 2 sourced rounds
$26M$52M$78M$104MAUGMAYFEBNOVAUGMAYFEBNOV$104MSeries A · Jul 7, 2021A · JUL '21$17.25M Series B+ · Oct 22, 2025$17.25M B+ · OCT '25$87M Series B+ · Nov 19, 2026$87M B+ · NOV '26

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

DateRoundAmountLeadSource
Series B+$87MFF-Prime Capitalthepharmaletter.com
Series B+$17.25MAAdjuvant Capitalvcnewsdaily.com
Series AundisclosedAAdjuvant Capitalfinsmes.com

Timeline

  1. Website created

Founders and team

Investors

Companies like VitriVax

Other companies backed by F-Prime Capital

F-Prime Capital portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/vitrivax (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy